Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Q3 2024 Earnings Call Transcript February 10, 2025 Roivant Sciences Ltd. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.24. Operator: Ladies and gentlemen, thank you for ...

Ladies and gentlemen, thank you for standing by. Welcome to Roivant second quarter 2024 earnings call. (Operator Instructions) Please be advised that today's conference is being recorded. I would like ...

Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech's second cut to product revenue guidance in six months. Moderna shares (MRNA) fell 2% in ...

Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. This is the second piece of good news this month for Modera, which won $590 ...

Infants should receive one dose of the vaccine just after birth, followed by a second dose at 1–2 months and the third dose at 6–18 months. Adults ages 19–59 should receive the hepatitis B vaccine in ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Biotechnology company Moderna (NASDAQ:MRNA) gained the spotlight in the medical sector as a leader in the race toward a COVID-19 vaccine. Its messenger RNA (mRNA) technology garnered acclaim as a ...

WASHINGTON — Senators vetting the nomination of Pete Hegseth for defense secretary received an affidavit Tuesday from a former sister-in-law alleging that the onetime Fox News host was abusive ...

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...